RNA VLP Vectors
RNA-containing VLP Vectors (VLPV) represent an innovative vaccine technology, which resembles VLPs. Unlike VLPs that represent “empty” replicas of viruses, VLPVs contain RNA vectors “stuffed” inside liposomes or VLPs. After vaccination, RNA vectors are released from liposomes or VLPs with the purpose of expressing vaccine antigen and inducing immune response. Medigen uses RNA vector technology to develop cancer vaccines.
